TH
THRM.NS
—
NSE (India)
Commodity Chemicals
Thirumalai Chemicals Ltd
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
—
P/E
—
EV / Rev
—
Div yield
0,00 %
Op margin
-0,3 %
ROE
-4,0 %
Net margin
-2,2 %
Debt / equity
1,55
Beta
—
52w range
—
Volume
—
Day range
—
Prev close
$42,08
Open
—
Next earnings
—
Ex-dividend
—
TR 1Y
—
About
Thirumalai Chemicals Ltd is a chemical manufacturing company that produces and sells commodity chemicals, primarily serving the industrial and agricultural sectors.
Business. Thirumalai Chemicals Ltd (THRM.NS) is an Indian company operating in the commodity chemicals industry within the basic materials sector. The firm is headquartered in India and is primarily listed on the National Stock Exchange of India. As specific segment and geographic details are not provided, the company is described at the industry level as a producer of commodity chemicals.
Classification92 %
SectorBasic Materials
Business sectorChemicals
IndustryCommodity Chemicals
ActivityChemicals
Generated · model-assisted
Sell-side consensus
—consensus pending
— buy— hold— sell
Avg 12m price target—
At a glance
Score
—
not yet scored
Valuation
—
valuation pending
Analysts
—
not yet wired
Ownership→
American Century Investment Management, Inc.
largest disclosed fund holder
Profitability→
-4,0 %
return on equity
Quality
—
not yet scored
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
— missing data
News & coverage
0Sector rotation
Sector1D1Mvs mkt
Materials · THIS SECTOR+2,3 %+6,6 %+1,7 %
Communication Services+2,2 %−5,5 %+1,6 %
Energy+0,6 %+3,3 %+0,0 %
Health Care+0,6 %−0,8 %+0,0 %
Information Technology+0,6 %+6,7 %+0,0 %
Consumer Discretionary+0,4 %+7,6 %−0,2 %
Financials−0,3 %−2,8 %−0,9 %
Consumer Staples−0,4 %+2,5 %−1,0 %
Real Estate−0,7 %+10,9 %−1,3 %
Industrials−1,9 %−3,1 %−2,5 %
Utilities−1,9 %+28,2 %−2,5 %
Developing storylines
No tracked sagas currently linked to THRM.NS. Browse all sagas →
Analysis
AI analysis
Generated · analysis pipeline · tier hybrid · as of 2026-08-04
↑ At a glance
Opportunity
— missing data
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
— missing data
Signals & dispatch
peak dispatch · —
Composite-score breakdown
Synthesis
Business
Thirumalai Chemicals Ltd (THRM.NS) is an Indian company operating in the commodity chemicals industry within the basic materials sector. The firm is headquartered in India and is primarily listed on the National Stock Exchange of India. As specific segment and geographic details are not provided, the company is described at the industry level as a producer of commodity chemicals.
Classification92 %
SectorBasic Materials
Business sectorChemicals
IndustryCommodity Chemicals
ActivityChemicals
AI synthesis
GENERATEDThirumalai Chemicals Ltd has a debt-to-equity ratio of 1.55, indicating a relatively high level of leverage. The company's liquidity position is assessed as medium, with a current ratio of 1.04, suggesting limited short-term liquidity cushion. Free cash flow is negative at -6,081.4 million INR, and operating cash flow is also negative at -658.8 million INR, indicating cash flow challenges.
Profitability metrics are weak, with a return on equity of -3.99% and a return on assets of -1.21%, both significantly below the industry median for Commodity Chemicals. The company reported a net loss of 461 million INR and an operating loss of 63.9 million INR, reflecting poor operational performance.
The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to sector-specific risks. No recent segment disclosures or geographic breakdowns are available in the latest filings.
The company's revenue growth is expected to remain flat or decline in the current fiscal year, with no clear signs of recovery in the next fiscal year. The negative operating and net income suggest a lack of momentum in improving profitability. Capital expenditures were -6,129 million INR, indicating a significant outflow of cash for investments.
The risk assessment highlights liquidity concerns, with negative net cash after subtracting total debt. The company's dilution risk is assessed as low, with no recent signs of share issuance or dilution pressure. However, the negative free cash flow and high leverage could limit the company's ability to service debt or fund operations without external financing.
No recent filings or transcripts are available in the provided data to assess management commentary or strategic direction. The company's financial performance and risk profile suggest a need for close monitoring of liquidity and profitability trends.
Key takeaways
- Thirumalai Chemicals Ltd is operating at a net loss with negative free cash flow, indicating significant financial stress.
- The company's debt-to-equity ratio of 1.55 and negative net cash position highlight liquidity and leverage risks.
- Return on equity and return on assets are both negative, suggesting poor capital efficiency and profitability.
- The company's business is concentrated in a single segment, increasing exposure to sector-specific risks.
- No recent strategic or operational developments are disclosed, and the outlook for revenue growth is uncertain.
Bull / Bear case
Generated · model-assisted— missing data
In focus — financials by report
Valuation
Market price
$205,23
Market cap
—
Enterprise valueⓘ
—
P/Eⓘ
—
Non-GAAP P/Eⓘ
—
EV / Revenueⓘ
—
EV / Op incomeⓘ
—
EV / OCFⓘ
—
P / Bⓘ
—
P / Tangible bookⓘ
—
Tangible book
$11.56B
Net cashⓘ
-$16.48B
Current ratioⓘ
1.0
Debt / equityⓘ
1.6
ROAⓘ
-1.2%
ROEⓘ
-4.0%
Cash conversionⓘ
143.0%
CapEx / revenueⓘ
-29.9%
SBC / revenueⓘ
—
Dilution ratioⓘ
0.0%
Revenue by segment
Business relationships
Business relationships34 disclosed relationships · 1 type · extracted from filings & disclosures
Subsidiaries34
EX21:01980083878dEX21:01980083878dSubsidiarie97%
EX21:0d1a12b0b809EX21:0d1a12b0b809Subsidiarie97%
EX21:0e382117a1b0EX21:0e382117a1b0Subsidiarie97%
EX21:15de86b7256eEX21:15de86b7256eSubsidiarie97%
EX21:1c7f74b01bc4EX21:1c7f74b01bc4Subsidiarie97%
EX21:207675ccfa2fEX21:207675ccfa2fSubsidiarie97%
EX21:24a542b82163EX21:24a542b82163Subsidiarie97%
EX21:301c7d93c1f8EX21:301c7d93c1f8Subsidiarie97%
EX21:348d21051292EX21:348d21051292Subsidiarie97%
EX21:4a86f4384650EX21:4a86f4384650Subsidiarie97%
EX21:4b0328fa0a1dEX21:4b0328fa0a1dSubsidiarie97%
EX21:616a11a0ff26EX21:616a11a0ff26Subsidiarie97%
EX21:66925c39eaaaEX21:66925c39eaaaSubsidiarie97%
EX21:66aaac1288bfEX21:66aaac1288bfSubsidiarie97%
EX21:6d57026a9af8EX21:6d57026a9af8Subsidiarie97%
EX21:6fe65bfe1fa4EX21:6fe65bfe1fa4Subsidiarie97%
EX21:73edd6b6503dEX21:73edd6b6503dSubsidiarie97%
EX21:834adf926090EX21:834adf926090Subsidiarie97%
EX21:834d8d27826eEX21:834d8d27826eSubsidiarie97%
EX21:8acafde41c4aEX21:8acafde41c4aSubsidiarie97%
EX21:91413720f9d2EX21:91413720f9d2Subsidiarie97%
EX21:934e07a39cf3EX21:934e07a39cf3Subsidiarie97%
EX21:9ace03ce469bEX21:9ace03ce469bSubsidiarie97%
EX21:9b89e471d29eEX21:9b89e471d29eSubsidiarie97%
EX21:9f34e7af107dEX21:9f34e7af107dSubsidiarie97%
EX21:9f9e08702387EX21:9f9e08702387Subsidiarie97%
EX21:a3dce1c0df14EX21:a3dce1c0df14Subsidiarie97%
EX21:a719dfe677edEX21:a719dfe677edSubsidiarie97%
EX21:b822c0742edbEX21:b822c0742edbSubsidiarie97%
EX21:c41d1217f3d2EX21:c41d1217f3d2Subsidiarie97%
EX21:cdc6e38435d0EX21:cdc6e38435d0Subsidiarie97%
EX21:e7bf2d1e2669EX21:e7bf2d1e2669Subsidiarie97%
EX21:faa96ee6d7cbEX21:faa96ee6d7cbSubsidiarie97%
EX21:fcd3f0b3cbb0EX21:fcd3f0b3cbb0Subsidiarie97%
Supply chain
— missing data
Peer comparison
— missing data
Market position
Stress test
— missing data
Predictor forecast
Options
— missing data
Short squeeze
— missing data
Earnings-call key lines
— missing data
Estimate revisions
consensus EPS · 26-week trend— missing data
Sell-side observations
— missing data
Themes
— missing data
ESG
— missing data
Risk factors
Dilution riskLow
Liquidity riskMedium
Filing-based flags
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Op Margin-0,3 %Bottom quartile
Net Margin-2,2 %Bottom quartile
ROE-4,0 %Bottom quartile
Capex / Rev-29,9 %Bottom quartile
D/E1,55Bottom quartile
Cash Conv1,43Above median
Corporate actions / M&A
— missing data
FX exposure
— missing data
Comparable transactions
— missing data
Derivatives & instruments
— missing data
Actions
Ask Handelsavisen
— missing data
Data sources
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
How metrics are computed
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
Source documents
- Thirumalai Chemicals Ltd Market data — financials · 2026-05-29
Ownership & reference
Top holders
- Investment Managers · as of 2026-03-310,01 %$21M
- Investment Managers · as of 2026-03-310,01 %$41M
- Investment Managers · as of 2026-03-310,01 %$15M
- Investment Managers · as of 2024-06-300,01 %$241M
- Institutional Investor · as of 2026-03-310,00 %$13M
- Investment Managers · as of 2026-03-310,00 %$5M
- Investment Managers · as of 2026-03-310,00 %$14M
- Institutional Investor · as of 2022-09-300,00 %$0M
- Investment Managers · as of 2025-12-310,00 %$121M
- Funds · as of 2026-03-310,00 %$10M
- Investment Managers · as of 2026-03-310,00 %$3M
- Investment Managers · as of 2026-03-310,00 %$21M
- Investment Managers · as of 2026-03-310,00 %$9M
- Investment Managers · as of 2026-03-310,00 %$35M
- Institutional Investor · as of 2026-03-310,00 %$6M
- Investment Managers · as of 2024-12-310,00 %$3M
- Brokerage Firms · as of 2026-03-310,00 %$3M
- Investment Managers · as of 2026-03-310,00 %$1M
- Investment Managers · as of 2026-03-310,00 %$12M
- Investment Managers · as of 2026-03-310,00 %$5M
- Investment Managers · as of 2026-03-310,00 %$4M
- Investment Managers · as of 2026-03-310,00 %$2M
- Investment Managers · as of 2026-03-310,00 %$2M
- Investment Managers · as of 2026-03-310,00 %$1M
- Institutional Investor · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Brokerage Firms · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Institutional Investor · as of 2026-03-310,00 %$0M
- Institutional Investor · as of 2026-03-310,00 %$0M
Leadership
- Phil M. EylerPresident, Chief Executive Officer, Director
Insider activity
Net selling0 buys · 1 sellsnet -$203K17 insiders · last 365d
- SVP and General Counsel · Common StockSold 4 700 @ $43,21$203K · 2026-07-29
- Director · Common StockOther 4 292 · 2026-05-14
- Director · Common StockOther 4 292 · 2026-05-14
- Director · Common StockOther 4 292 · 2026-05-14
- Director · Common StockOther 4 292 · 2026-05-14
- Director · Common StockOther 4 292 · 2026-05-14
- Director · Common StockOther 4 292 · 2026-05-14
- Director · Common StockOther 4 292 · 2026-05-14
- Director · Common StockOther 4 292 · 2026-05-14
- President, Gentherm Tech. · Common StockOther 1 115 @ $28,64$32K · 2026-03-23
- Chief Accounting Officer · Common StockOther 353 · 2026-03-23
- Chief Accounting Officer · Common StockOther 102 @ $28,64$3K · 2026-03-23
- SVP Global Ops & Supply Chain · Common StockOther 2 121 · 2026-03-23
- SVP Global Ops & Supply Chain · Common StockOther 607 @ $28,64$17K · 2026-03-23
- SVP, CHRO · Common StockOther 2 121 · 2026-03-23
- SVP, CHRO · Common StockOther 961 @ $28,64$28K · 2026-03-23
- SVP, Chief Strategy Officer · Common StockOther 2 474 · 2026-03-23
- SVP, Chief Strategy Officer · Common StockOther 710 @ $28,64$20K · 2026-03-23
- SVP and General Counsel · Common StockOther 2 121 · 2026-03-23
- SVP and General Counsel · Common StockOther 925 @ $28,64$26K · 2026-03-23
- President, Gentherm Tech. · Common StockOther 2 474 · 2026-03-23
- VP & General Manager · Common StockOther 266 · 2026-03-23
- SVP Global Ops & Supply Chain · Common StockOther 7 665 · 2026-03-17
- EVP, CFO, Treasurer · Common StockOther 14 049 · 2026-03-17
- Chief Accounting Officer · Common StockOther 1 599 · 2026-03-17
Short positioning
1.6Mshares short+2.5% vs prior
5.42days to cover
71.6%short of daily vol
128fails-to-deliver
as of 2026-07-15 · short-interest report (free)
Geographic breakdown
— missing data
Listings · one canonical issuer
all listings resolve to the canonical
THRM.NSCanonical
NSE (India) · USD
Intel & risk
peak dispatch · —
OSINT findings
Dilution riskLow
Liquidity riskMedium
Net cash is negative after subtracting total debt.
Relationship graph
This companySectorSubsidiaries
Evidence & claims
From filings & derived data- Gross profit (YoY) (2025-12-31 vs 2024-12-31): -1.2%Derived (calculated)
- Gross margin (FY 2025-12-31): 24.2%Derived (calculated)
- Current ratio (FY 2025-12-31): 1.92xDerived (calculated)
- Debt-to-equity (FY 2025-12-31): 0.94xDerived (calculated)
- Capex (YoY) (2025-12-31 vs 2024-12-31): -24.1%Derived (calculated)
- Cash & equivalents (YoY) (2025-12-31 vs 2024-12-31): 19.9%Derived (calculated)
- Cost of revenue (YoY) (2025-12-31 vs 2024-12-31): 4.3%Derived (calculated)
- EPS (basic) (YoY) (2025-12-31 vs 2024-12-31): -71.2%Derived (calculated)
- EPS (diluted) (YoY) (2025-12-31 vs 2024-12-31): -71.4%Derived (calculated)
- Long-term debt (YoY) (2025-12-31 vs 2024-12-31): -14.1%Derived (calculated)
- Operating cash flow (YoY) (2025-12-31 vs 2024-12-31): 6.5%Derived (calculated)
- Operating income (YoY) (2025-12-31 vs 2024-12-31): -22.7%Derived (calculated)
- R&D expense (YoY) (2025-12-31 vs 2024-12-31): 6.8%Derived (calculated)
- Revenue (YoY) (2025-12-31 vs 2024-12-31): 2.9%Derived (calculated)
- Shareholders' equity (YoY) (2025-12-31 vs 2024-12-31): 16.8%Derived (calculated)
- Total assets (YoY) (2025-12-31 vs 2024-12-31): 11.9%Derived (calculated)
- Total liabilities (YoY) (2025-12-31 vs 2024-12-31): 7.2%Derived (calculated)
- Pre-tax income (annual): USD 35.84MSEC XBRL filing
- EPS (diluted) (annual): USD-PER-SHARES 1SEC XBRL filing
- Gross profit (annual): USD 362.18MSEC XBRL filing
- R&D expense (annual): USD 94.76MSEC XBRL filing
- EPS (basic) (annual): USD-PER-SHARES 1SEC XBRL filing
- Long-term debt (annual): USD 189.07MSEC XBRL filing
- Current liabilities (annual): USD 404.31MSEC XBRL filing
Showing 24 of 58 surfaced claims.
Atomic claims from regulatory filings and derived calculations. Provenance shown as source kind only.
The Thread
Everything we know, in order2026-07-29INSIDERKauffman Wayne S III sold 4.7k sh — SVP and General Counsel ~$203k
2026-07-23 00:00 UTCTRANSCRIPTEarnings call — Q3 2026
2026-07-23EVENTQ2 2026 earnings (expected) estimated date
2026-05-14 00:00 UTCINSIDER8 insider transactions — 2026-05
2026-05-14 00:00 UTCINSIDER8 insider transactions — 2026-05
2026-05-14INSIDERWashington Kenneth E transacted 4.3k sh — Director
2026-05-14INSIDERStacey John transacted 4.3k sh — Director
2026-05-14INSIDERMeter Elizabeth transacted 4.3k sh — Director
2026-05-14INSIDERKummeth Charles R. transacted 4.3k sh — Director
2026-05-14INSIDERKowalchik Laura Michele transacted 4.3k sh — Director
2026-05-14INSIDERHundzinski Ronald T transacted 4.3k sh — Director
2026-05-14INSIDERHeinzmann David W transacted 4.3k sh — Director
2026-05-14INSIDERDesormiere Sophie transacted 4.3k sh — Director
2026-03-23 00:00 UTCINSIDER22 insider transactions — 2026-03 · net sell $127k
2026-03-23 00:00 UTCINSIDER22 insider transactions — 2026-03 · net sell $127k
2026-03-23INSIDERStocker Thomas transacted 1.1k sh — President, Gentherm Tech. ~$32k
2026-03-23INSIDERNicholas Breisacher transacted 353 sh — Chief Accounting Officer
2026-03-23INSIDERNicholas Breisacher transacted 102 sh — Chief Accounting Officer ~$3k
2026-03-23INSIDERBarkas Rafael transacted 2.1k sh — SVP Global Ops & Supply Chain
2026-03-23INSIDERBarkas Rafael transacted 607 sh — SVP Global Ops & Supply Chain ~$17k
2026-03-23INSIDERRunyon Barbara J transacted 2.1k sh — SVP, CHRO
2026-03-23INSIDERRunyon Barbara J transacted 961 sh — SVP, CHRO ~$28k
2026-03-23INSIDERWilson Jaymi transacted 2.5k sh — SVP, Chief Strategy Officer
2026-03-23INSIDERWilson Jaymi transacted 710 sh — SVP, Chief Strategy Officer ~$20k
2026-03-23INSIDERKauffman Wayne S III transacted 2.1k sh — SVP and General Counsel
2026-03-23INSIDERKauffman Wayne S III transacted 925 sh — SVP and General Counsel ~$26k
2026-03-23INSIDERStocker Thomas transacted 2.5k sh — President, Gentherm Tech.
2026-03-23INSIDERWang Chenglong transacted 266 sh — VP & General Manager
2026-03-17INSIDERBarkas Rafael transacted 7.7k sh — SVP Global Ops & Supply Chain
2026-03-17INSIDERDouyard Jonathan C transacted 14.0k sh — EVP, CFO, Treasurer
2026-03-17INSIDERNicholas Breisacher transacted 1.6k sh — Chief Accounting Officer
Showing the 40 most recent of 43 entries.
The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04
Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data
Premium coverage